SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-22-048398
Filing Date
2022-04-21
Accepted
2022-04-21 16:15:54
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm223551d2_defa14a.htm DEFA14A 11714
2 GRAPHIC tm223551d2_defa14aimg001.jpg GRAPHIC 447386
3 GRAPHIC tm223551d2_defa14aimg002.jpg GRAPHIC 328171
  Complete submission text file 0001104659-22-048398.txt   1081108
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34620 | Film No.: 22841605
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences